Publication Cover
Archives of Andrology
Journal of Reproductive Systems
Volume 29, 1992 - Issue 3
44
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Prostatic Specific Antigen and Immunoglobulin Binding Factor in Human Seminal Plasma and Prostate

, &
Pages 225-231 | Published online: 09 Jul 2009
 

Abstract

Antibodies raised against prostatic specific antigen (PSA) and immunoglobulin binding factor (IgBF) of human seminal plasma (SP) were used to localize the antigens in various tissues by Western blot. Both antigens were found only in the prostate, including benign prostatic hypertrophy and prostatic adenocarcinoma. The polyclonal anti-PSA antibodies stained five prostatic protein bands with estimated Mr values of 10, 14, 22, 25, and 33 kD, whereas anti-IgBF antibodies stained a single 16-kD protein. No cross-reaction occurred between the two antibodies. When anti-PSA antibodies were used an additional protein with an estimated Mr of 35 JcD was detected in the extract of benign prostatic hypertrophy, but not with normal prostate or prostatic cancer. When SP and prostatic proteins were analyzed by SDS-PAGE under nonreducing condition and immunoblot with both antibodies, immunoreactive proteins with estimated Mr of 125 and 140 kD, respectively, were stained, suggesting that both factors may be produced as an aggregated precursor molecule. Since IgBF was found only in the prostate, this component may be useful as a marker of prostatic tissue.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.